Levodopa–Carbidopa Intestinal Gel Reduces Dyskinesia in Parkinson Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Movement Disorders: Official Journal of the Movement Disorder Society
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Levodopa-Carbidopa Intestinal Gel Reduces Dyskinesia in Parkinson's Disease in a Randomized Trial
Mov. Disord. 2021 Nov 01;36(11)2615-2623, E Freire-Alvarez, E Kurča, L Lopez Manzanares, E Pekkonen, C Spanaki, P Vanni, Y Liu, O Sánchez-Soliño, LM BarbatoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.